DETECTION OF HEPATITIS-C VIREMIA IN CAUCASIAN PATIENTS WITH HEPATOCELLULAR-CARCINOMA

被引:17
|
作者
GARSON, JA
WICKI, AN
RING, CJA
JOLLER, H
ZALA, G
SCHMID, M
BUEHLER, H
机构
[1] UNIV HOSP ZURICH,ANAWA LABS,CH-8091 ZURICH,SWITZERLAND
[2] UNIV HOSP ZURICH,STADTSPITAL WAID,DEPT MED,CH-8091 ZURICH,SWITZERLAND
[3] UNIV HOSP ZURICH,DEPT CLIN IMMUNOL,CH-8091 ZURICH,SWITZERLAND
关键词
HEPATITIS-C; VIREMIA; HEPATOCELLULAR CARCINOMA; POLYMERASE CHAIN REACTION;
D O I
10.1002/jmv.1890380215
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Potential risk factors for the development of hepatocellular carcinoma were analysed in 40 Caucasian patients with this malignancy. A higher proportion (14 of 40; 35%) had evidence of hepatitis C virus (HCV) infection than had evidence of either hepatitis B virus (HBV) carriage (17.5%) or alcohol abuse (30%). In all 14 patients whose sera were reactive by HCV ELISA (Ortho second generation test), the presence of antibodies to HCV were confirmed by recombinant immunoblot assay (Ortho RIBA-2). Furthermore, two independent laboratories detected HCV-RNA in 10 of the 14 (71%) anti-HCV positive sera. Two additional sera were shown to contain HCV-RNA when reanalysed by a modified PCR using oligonucleotide primers designed to amplify a shorter fragment of the 5' noncoding region of the genome. Seven of the anti-HCV positive patients also had evidence of prior HBV infection and 2 admitted to alcohol abuse. HCV infection was the only identifiable risk factor in 6 patients. These data confirm the association between HCV infection and hepatocellular carcinoma and suggest that persistent viral replication accompanies tumour development in the majority of patients whose serum contains anti-HCV.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 50 条
  • [1] HEPATITIS-C AND HEPATOCELLULAR-CARCINOMA
    DIBISCEGLIE, AM
    SEMINARS IN LIVER DISEASE, 1995, 15 (01) : 64 - 69
  • [2] ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    LEVRERO, M
    TAGGER, A
    BALSANO, C
    DEMARZIO, E
    AVANTAGGIATI, ML
    NATOLI, G
    DIOP, D
    VILLA, E
    DIODATI, G
    ALBERTI, A
    JOURNAL OF HEPATOLOGY, 1991, 12 (01) : 60 - 63
  • [3] HEPATITIS-C VIRUS AND HEPATOCELLULAR-CARCINOMA
    TABOR, E
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 793 - 796
  • [4] HEPATITIS-C VIRUS AND HEPATOCELLULAR-CARCINOMA
    SANGIOVANNI, A
    COVINI, G
    RUMI, MG
    MARCELLI, R
    COLOMBO, M
    ARCHIVES OF VIROLOGY, 1992, : 70 - 75
  • [5] HEPATITIS-C VIRUS AND HEPATOCELLULAR-CARCINOMA
    ZALA, G
    HAVELKA, J
    ALTORFER, J
    JOLLERJEMELKA, HJ
    RISTI, B
    MEIER, B
    SCHMID, M
    BUHLER, H
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 122 (06) : 194 - 197
  • [6] HEPATITIS-C VIRUS AND HEPATOCELLULAR-CARCINOMA
    KEW, MC
    FEMS MICROBIOLOGY REVIEWS, 1994, 14 (03) : 211 - 219
  • [7] DETECTION OF REPLICATIVE HEPATITIS-C VIRUS SEQUENCES IN HEPATOCELLULAR-CARCINOMA
    GERBER, MA
    SHIEH, YSC
    SHIM, KS
    THUNG, SN
    DEMETRIS, AJ
    SCHWARTZ, M
    AKYOL, G
    DASH, S
    AMERICAN JOURNAL OF PATHOLOGY, 1992, 141 (06): : 1271 - 1277
  • [8] LOW PREVALENCE OF HEPATITIS-C VIRUS GENOME DETECTED BY PCR IN SERUM OF CAUCASIAN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    THELU, MA
    ZARSKI, JP
    DARDELET, D
    LUNEL, F
    SEIGNEURIN, JM
    JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) : 415 - 416
  • [9] HEPATOCELLULAR-CARCINOMA IN PATIENTS INFECTED WITH DIFFERENT HEPATITIS-C GENOTYPES
    ZEIN, NN
    POTERUCHA, JJ
    WIESNER, RH
    GROSS, JB
    GOSSARD, AA
    WENDT, NK
    MITCHELL, PS
    GERMER, JJ
    PERSING, DH
    GASTROENTEROLOGY, 1995, 108 (04) : A1207 - A1207
  • [10] ANTIBODY TO HEPATITIS-C VIRUS IN HEPATOCELLULAR-CARCINOMA
    DUCREUX, M
    DUSSAIX, E
    BRIANTAIS, MJ
    JACQUES, L
    BUFFET, C
    PELLETIER, G
    YVART, J
    ETIENNE, JP
    LANCET, 1990, 335 (8684): : 301 - 301